The year eCurv spent pitching its energy management software to potential customers has taught its founder a few lessons.
“The opportunity is much bigger than we thought,” said Edison Almeida, founder and chief executive of the Cambridge, MA, startup, which raised... Read more »
CyPhy Works’ co-founder and CEO Helen Greiner knows what it takes to get robots into the hands of consumers. As a co-founder of iRobot, she helped create the Roomba vacuum, which brought affordable and user-friendly robots into the home. Now... Read more »
Bronto Software’s bread-and-butter business is helping companies understand what their customers browse and buy online—information that can then be used to nudge consumers to buy even more.
This type of “marketing automation”—the ability to analyze consumer behavior in order to... Read more »
A new cleantech-focused investment fund is forming in Seattle.
The Element 8 Fund is emerging from the Element 8 angel investing group (formerly the Northwest Energy Angels) as a way to give individual accredited investors a chance to broaden their portfolios... Read more »
When San Diego-based NuVasive (NASDAQ: NUVA) disclosed the sudden departure of chairman and CEO Alex Lukianov about four weeks ago, a NuVasive spokeswoman said it was unrelated to a two-year investigation of NuVasive by the Office of Inspector General (OIG)... Read more »
As it heads toward an IPO try, New York biotech Kadmon is lightening its load. The firm announced today it has spun out a gene-therapy subsidiary and expects it to have four products in clinical trials next year with a focus... Read more »
Detroit’s first-ever, cross-border healthcare IT hackathon kicks off this evening, as teams from around Michigan and Canada gather at Wayne State University to develop their mobile app and startup ideas before they then spend the weekend refining them. On Sunday, the... Read more »
After spending 13 years providing security and authorization software for doctors, Imprivata has made its first acquisition and is adding a patient identification tool to its product line.
Imprivata (NYSE: IMPR) is paying $19.1 million upfront to purchase HT Systems... Read more »
Kidney disease drug developer NephroGenex (NASDAQ: NRX) is raising $30 million in a secondary stock offering to expand the late-stage clinical trial of its lead drug.
In paperwork filed with securities regulators, the Raleigh, NC-based company says it expects to... Read more »